Out of that group, 67 people developed NAION (~0.0629%)
A pill containing 25 mg of semaglutide delivers results comparable to Novo Nordisks 2.4 mg injectable, according to the press release
The American Medical Association, American Diabetes Association, and other medical organizations recognize obesity as a chronic condition requiring ongoing management, similar to hypertension or diabetes
ileus, intestinal obstruction, severe constipation including fecal impaction Hypersensitivity:anaphylaxis, angioedema, rash, urticaria Hepatobiliary:cholecystitis, cholecystectomy Neurologic:dysesthesia, headache Pulmonary: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation
Semaglutide binds to and activates receptors in your pancreas and surrounding tissues